MyFinsight
Home
Blog
About
Marketable debt securities
$125,418K
(38.25%↑ Y/Y)
Cash and cash
equivalents
$17,076K
(-45.78%↓ Y/Y)
Prepaid expenses and
other current assets
$3,658K
(27.23%↑ Y/Y)
Total current assets
$146,152K
(16.84%↑ Y/Y)
Marketable debt
securities, non-current
$19,356K
(-17.25%↓ Y/Y)
Other assets
$5,920K
(92.96%↑ Y/Y)
Operating lease
right-of-use asset
$2,602K
(-30.15%↓ Y/Y)
Property and equipment,
net
$1,318K
(44.52%↑ Y/Y)
Restricted cash,
non-current
$745K
(0.00%↑ Y/Y)
Total assets
$176,093K
(12.21%↑ Y/Y)
Total liabilities and
stockholders equity
$176,093K
(12.21%↑ Y/Y)
Total stockholders
equity
$161,311K
(11.69%↑ Y/Y)
Total liabilities
$14,782K
(18.16%↑ Y/Y)
Accumulated deficit
-$341,869K
(-25.75%↓ Y/Y)
Accumulated other
comprehensive income (loss)
-$363K
(-571.43%↓ Y/Y)
Additional paid-in capital
$503,484K
(20.98%↑ Y/Y)
Total current
liabilities
$13,319K
(36.45%↑ Y/Y)
Operating lease
liability, non-current
$1,463K
(-46.78%↓ Y/Y)
Common stock,
59,083,935 and 53,587,260...
$59K
(51.28%↑ Y/Y)
Accrued expenses and
other current...
$7,370K
(125.87%↑ Y/Y)
Accounts payable
$4,663K
(-12.00%↓ Y/Y)
Operating lease liability
$1,286K
(7.26%↑ Y/Y)
Back
Back
Balance Sheet
Protara Therapeutics, Inc. (TARA)
Protara Therapeutics, Inc. (TARA)
source: myfinsight.com